Fulgent Genetics (MEX:FLGT) Short-Term Debt : MXN8 Mil (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Fulgent Genetics Short-Term Debt?

Fulgent Genetics's Short-Term Debt for the quarter that ended in Jun. 2024 was MXN8 Mil.

Fulgent Genetics's quarterly Short-Term Debt declined from Dec. 2023 (MXN20 Mil) to Mar. 2024 (MXN7 Mil) but then increased from Mar. 2024 (MXN7 Mil) to Jun. 2024 (MXN8 Mil).

Fulgent Genetics's annual Short-Term Debt declined from Dec. 2021 (MXN437 Mil) to Dec. 2022 (MXN402 Mil) and declined from Dec. 2022 (MXN402 Mil) to Dec. 2023 (MXN20 Mil).

Fulgent Genetics Short-Term Debt Historical Data

The historical data trend for Fulgent Genetics's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fulgent Genetics Short-Term Debt Chart

Fulgent Genetics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

298.76

436.62

402.36

20.08

Fulgent Genetics Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Short-Term Debt	Get a 7-Day Free Trial															78.18	50.34	20.08	6.85	7.55

Fulgent Genetics Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Fulgent Genetics Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Fulgent Genetics's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Fulgent Genetics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fulgent Genetics Inc (MEX:FLGT) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

FLGT:USA 7F0:Germany

Address

4978 Santa Anita Avenue, Temple City, CA, USA, 91780

Website

https://www.fulgentgenetics.com

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.